Scaling Biotech

Scaling Biotech

Home
Archive
About
The first "AI Scientist" won't be a chat bot
I’ve been wanting to write about the interesting work that FutureHouse has been doing on reasoning models for biology, but I’m torn about how to frame…
 • 
Jesse Johnson
Did a foundation model just solve virtual small molecule screening?
Last week, a team of researchers at MIT, with support from Recursion, published a new foundation model called Boltz-2 that a lot of people are very…
 • 
Jesse Johnson
Can AI solve drug repurposing?
Nature Medicine recently published an article called A foundation model for clinician-centered drug repurposing that caught my attention because its use…
 • 
Jesse Johnson
Can you model biology mechanistically?
As part of the new direction that I’ve been taking this newsletter in, I’ve been exploring a bunch of different scientific applications of AI in pharma…
 • 
Jesse Johnson
2
Are foundation models the new moat?
Back in April, Tempus AI announced a strategic agreement with the pharma company AstraZeneca and a startup called Pathos, to build a Biology Foundation…
 • 
Jesse Johnson
Autonomous Discovery Starts with Automation
Two weeks ago, I wrote about an emerging category of software using LLMs to help labs translate manual experiment protocols into automation scripts.
 • 
Jesse Johnson
1
Can an AI beat an in vivo model?
Last week, Axiom Bio came out of stealth mode with the goal of eliminating drug toxicity without using animals.
 • 
Jesse Johnson
1
Scaling Biotech
Scaling Biotech
Industry news, trends and analysis for life science SaaS
Recommendations
View all 12
Asimov Press
Asimov Press
Asimov Press
User's avatar
Eric's Data Science Newsletter
Eric J. Ma
Biocene thoughts
Biocene thoughts
Dr. Shelby
Decoding Bio
Decoding Bio
Decoding
The Connected Ideas Project
The Connected Ideas Project
Alexander Titus

Scaling Biotech

AboutArchiveRecommendationsSitemap
© 2025 Jesse Johnson
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture